Abstract
Paraneoplastic cerebellar degeneration (PCD) is a paraneoplastic neurological syndrome that is rarely accompanied by seropositivity with a combination of multiple antibodies. We herein report a 50-year-old man with PCD accompanied by small-cell lung cancer (SCLC). This patient was seropositive for anti-glutamic acid decarboxylase 65, anti-SRY-related HMG-box gene 1 and anti-voltage-gated calcium channel antibodies. After chemoradiation therapy without immunotherapy, cerebellar ataxia of the trunk and limbs markedly improved, along with a notable amelioration of SCLC. This case suggests that tumor therapy should be started immediately and that a panel of anti-neuronal antibodies should be evaluated when PCD with SCLC is suspected.
Author supplied keywords
Cite
CITATION STYLE
Takahashi, N., Igari, R., Iseki, C., Kawahara, H., Suzuki, D., Suzuki, Y., … Ohta, Y. (2024). Paraneoplastic Cerebellar Degeneration Accompanied by Seropositivity for Anti-GAD65, Anti-SOX-1 and Anti-VGCC Antibodies Due to Small-cell Lung Cancer. Internal Medicine, 63(6), 857–860. https://doi.org/10.2169/internalmedicine.0738-22
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.